View the public protocol
Pfizer, Inc, Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, HealthPartners Institute, Kaiser Permanente Southern California. Epidemiology of Guillain-Barré Syndrome and Risk Associated with Exposure to ABRYSVO Among Vaccinees 18-59 Years of Age in the United States (EUPAS1000000629). Amsterdam: European Medicines Agency (EMA); 2025 Jun 27 - Available from: https://catalogues.ema.europa.eu/node/4532/administrative-details
